Can unbiased single-cell analysis of immune cells improve data-driven selection of tailored therapies in human atherosclerosis?
Atherosclerosis is a heterogenous disease characterized by immune infiltration of the arterial wall in response to tissue damage and systemic inflammation. Gaining a deeper knowledge of the immune contexture of atherosclerotic tissue, disease-specific molecular signatures and cell variation in patients is needed to design tailored therapies targeting the inflammatory dysfunction in these patients.
7 February 2017, 13:00 (Tuesday, 4th week, Hilary 2017)
Kennedy Institute of Rheumatology, Headington OX3 7LF
Bernard Sunley Lecture Theatre
Chiara Giannarelli, MD, PhD (Icahn School of Medicine, Mount Sinai)
Kennedy Institute of Rheumatology
Gintare Kolesnikovaite (Kennedy Institute of Rheumatology)
Organiser contact email address:
Prof Sir Marc Feldmann (University of Oxford),
Prof Claudia Monaco (University of Oxford)
Kennedy Institute Seminars
Members of the University only